PHILADELPHIA, PA — As vaccination gaps persist across the United States, GSK announced it has awarded $2 million in grants to ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV poses a higher risk of complications in adults, especially those with ...

GSK and the National Senior Games team up to spotlight RSV risk, prevention, and the power of proactive health conversations National TV special “Redefining Aging” to launch in September, spotlighting ...

GSK supports seasonal flu immunization in the US by shipping FLULAVAL (Influenza Vaccine) and FLUARIX (Influenza Vaccine) in advance of flu season PHILADELPHIA--(BUSINESS WIRE)-- GSK plc (LSE/NYSE: ...